Keyphrases
Preoperative Staging
100%
Positron Emission tomography-CT
100%
Lung Cancer Staging
100%
Randomized Controlled Trial
100%
Thoracotomy
40%
Cost-effectiveness
30%
Non-small Cell Lung Cancer (NSCLC)
30%
Comorbidity
30%
Willingness to Pay
20%
Healthcare Sector
20%
Full Health
20%
Number-needed-to-treat
20%
Confidence Interval
20%
Resource Use
10%
Cost Savings
10%
Incremental Cost-effectiveness Ratio
10%
Incremental Cost
10%
CT-based
10%
Hospital Services
10%
Hospital Costs
10%
Computed Tomography
10%
Medicine and Dentistry
Randomized Controlled Trial
100%
positron emission tomographic scan
100%
Lung Cancer
100%
Cost-Effectiveness Analysis
100%
Health Care Cost
40%
Thoracotomy
40%
Non Small Cell Lung Cancer
30%
Comorbidity
30%
Numbers Needed to Treat
20%
Health Care
20%
Arm
10%
Hospital Cost
10%
Nursing and Health Professions
Lung Cancer
100%
Cost Effectiveness Analysis
100%
positron emission tomographic scan
100%
Thoracotomy
40%
Comorbidity
30%
Non Small Cell Lung Cancer
30%
Confidence Interval
20%
Numbers Needed to Treat
20%
Health Care Cost
20%
Cost Control
10%
Incremental Cost-Effectiveness Ratio
10%
Hospital Cost
10%
X-Ray Computed Tomography
10%
Hospital Service
10%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Lung Cancer
100%
Comorbidity
100%
Non Small Cell Lung Cancer
100%
Number Needed to Treat
66%